Two monoclonal antibodies (MAbs) of the immunoglobulin G2A isotype, reacting with a Nocardia-specific 54-kDa antigen, were generated. As determined by Western blot (immunoblot), both MAbs reacted only with the 54-kDa band. As determined by indirect immunofluorescence or enzyme immunoassay with whole microorganisms, the MAbs did not react with Nocardia cells. One of the MAbs showed weak cross-reactivity with mycobacterial antigens, while the other showed no cross-reactivity.
Nocardiae are gram-positive, acid-fast-variable, branching, filamentous bacteria. Opportunistic nocardial disease, usually caused by Nocardia asteroides, has been associated with patients with an impaired host defense mechanism (17) . Infection in normal hosts (16) and nosocomially acquired infections (2) have also been reported.
Most of the serodiagnosis tests that have been developed have met with limited success because of cross-reactions of nocardial antigens with sera from cases of tuberculosis and leprosy (10, 18) or lack of sensitivity (5) . In a previous work (7), we partially purified a 54-kDa Nocardia-specific antigen which was first detected by Sugar et al. (1, 20) . We report here the production and characterization of two monoclonal antibodies (MAbs) to the 54-kDa Nocardia antigen as a step toward the standardization of reagents for immunodiagnosis of nocardiosis.
The 54-kDa antigen was partially purified by a previously published method (7) and was used for the immunization of a 3-month-old female LOU/C rat. On day 0, 15 ,ug of antigen in 350 ,ul of physiological saline and 550 ,ul of Freund's complete adjuvant was injected intraperitoneally. Intraperitoneal booster injections of 30 ,ug of antigen in 600 pl of physiological saline were given on days 14 and 16. On day 16, the spleen cells were fused with rat myeloma cells (IR983F) by using polyethylene glycol 4000 (3) (spleen cells/IR983F ratio, 5:1). Maintenance of hybridoma cultures and expansion of antibody-positive wells were carried out as described by Bazin (3) . The selected hybridoma cell lines were cloned by limiting dilution on peritoneal feeder cells.
The production of MAbs in ascites was performed as described previously (12, 19) , with minor modifications. A subcutaneous tumor was induced in a 2-month-old LOU/C rat by the injection of 2 x 106 hybridoma cells. Cells of this solid tumor were obtained by homogenization of peripheral tumor tissue in a Potter-Elvejhem homogenizer in phosphate-buffered saline (0.15 M, pH 7.2) (PBS). Two-milliliter aliquots of hybridoma suspensions were injected intraperitoneally into 3-month-old LOU/C.IgK-1b rats additioned with 2 ml of a 1:1 mixture of Freund's incomplete adjuvant and pristane. Clotting was induced by Topostasin (Roche Diagnostics, Division of Hoffmann-La Roche, Inc., Nutley, N.J.). The fluid phase was separated from the clot by centrifugation (10 min, 20,000 x g), and lipids were extracted with trichlorotrifluoroethane. Merthiolate (0.01%) and phenylmethylsulfonyl fluoride (0.8 mg/ml) were added before storage at -30°C.
The MAbs were purified from the ascitic fluid by allotypespecific affinity chromatography on an affinity matrix consisting of MAb MARK3 (Biosys, Compiegne, France) coupled to Sepharose-4B beads (Pharmacia, Uppsala, Sweden) (4, 19) .
Screening of MAbs was carried out according to standard enzyme immunoassay (EIA) procedures (8), using partially purified antigen and cell culture supernatants or purified MAbs as primary antibodies. By cloning by limiting dilution and ascites production, two clones were selected for further characterization. These clones were called EB-NAl and EB-NA2. Both MAbs were of the immunoglobulin G2A isotype, as determined by an indirect double sandwich EIA (13) .
The avidities of the selected MAbs were compared by using an indirect EIA procedure (21) . Twofold serial dilutions of purified MAbs, starting with a maximal concentration of 80 ,ug/ml in PBS-Tween 20, were added to the wells. MW In addition to the EIA, three methods were used to assess anti-54-kDa-antigen MAb activity. The Western blot (immunoblot) assay was performed as previously described (7). By this technique, only the 54-kDa band was revealed by both MAbs (Fig. 1 ). An indirect immunofluorescence test was made by following the procedure of Jimenez et al. (11) . The procedure using the EIA with whole Nocardia cells adsorbed on microtitration plates was previously described (6) . exhibited for EB-NAl. For EB-NA2, weak cross-reactivity was observed only with tuberculin (Fig. 2) .
The 54-kDa antigen was apparently not exposed to the microbial surface, as shown by indirect immunofluorescence experiments that were negative with all MAbs tested. This was confirmed by the lack of reaction of MAbs with whole Nocardia cells as determined by EIA.
Antigenic factors displaying a specificity for N. asteroides were characterized by El-Zaatari et al. (9) by using the enzyme-linked immunoelectrotransfer blot technique adapted to isofocused polyacrylamide gels. The relationship, if any, between the antigens detected by these MAbs and the 54-kDa antigen is unknown.
MAbs produced by Jimenez et al. (11) showed crossreactivity with Mycobacterium tuberculosis, M. intracellulare, M. scrofulaceum, M. kansasii, and M. fortuitum; this cross-reactivity may be viewed as undesirable for diagnostic purposes. MAbs which reacted strongly with Nocardia spp. were those that showed the highest degree of cross-reactivity with Mycobacterium spp. This was not totally unexpected, because both genera are antigenically related (15) and the antigens used were unpurified whole-cell extracts. However, they recognized surface antigenic components of the Nocardia spp., as demonstrated by indirect immunofluorescence.
The 54-kDa antigen was previously characterized as a glycoprotein (18a). When serum specimens were heated for 10 min at 100°C, reaction of MAbs with the 54-kDa antigen was abolished (data not shown). This observation suggests that our MAbs reacted with the protein part of the antigen and that the 54-kDa epitope was not located on the carbohydrate portion of the molecule.
The MAbs selected in this study are candidates for use in the development of a sensitive and specific diagnostic test for nocardiosis.
